Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report

We report two cases of patients who developed severe adverse drug reactions including persistent movement disorders, nausea, and vertigo during treatment with quetiapine at maximum daily doses ranging between 300 and 400 mg. The extensive hepatic metabolism of quetiapine is mainly attributed to cyto...

Descripción completa

Detalles Bibliográficos
Autores principales: Stäuble, Céline K., Lampert, Markus L., Mikoteit, Thorsten, Hatzinger, Martin, Hersberger, Kurt E., Meyer zu Schwabedissen, Henriette E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233787/
https://www.ncbi.nlm.nih.gov/pubmed/34204223
http://dx.doi.org/10.3390/ijms22126480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233787/
https://www.ncbi.nlm.nih.gov/pubmed/34204223
http://dx.doi.org/10.3390/ijms22126480

Ejemplares similares